Department of Health and Human Services Awarded a Contract to METACLIPSE THERAPEUTICS CORP for $354,957.00

Q: Where is METACLIPSE THERAPEUTICS CORP located?

3342 INTERNATIONAL PARK DR SE ATLANTA GEORGIA UNITED STATES

Signed on

9/4/2025, 12:00 AM

METACLIPSE THERAPEUTICS CORP Government Contract #75N91025C00038

METACLIPSE THERAPEUTICS CORP was awarded a contract with the United States Government for $354,957.00. The contract was awarded by the agency office NIH NCI, which is a division with the National Institutes of Health within the Department of Health and Human Services.

Summary of Award

The recipient of the federal contract is Metaclipse Therapeutics Corp, a small business based in Atlanta, Georgia, specializing in research and development in nanotechnology. The contract, funded by the Department of Health and Human Services through the National Institutes of Health, is for developing therapeutic or preventative technologies for pediatric cancers and rare cancers, with a total value of $354,957. A notable transaction includes the definitive contract awarded on September 4, 2025, for this specific project.

Contract Details

Contract ID75N91025C00038

Contract TypeD

Total Obligation$354,957.00

Exercised Options$354,957.00

Base Amount + Options$354,957.00

Date Signed2025-09-04

Contract DescriptionSBIR CONCEPT AWARD FOR DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS

Start Date2025-09-05

End Date2026-09-04

Agency Details

Awarding AgencyDepartment of Health and Human Services

Awarding Sub AgencyNational Institutes of Health

Awarding OfficeNIH NCI

Funding AgencyDepartment of Health and Human Services

Funding Sub AgencyNational Institutes of Health

Funding OfficeNIH NCI

Recipient Details

RecipientMETACLIPSE THERAPEUTICS CORP

Recipient Location3342 INTERNATIONAL PARK DR SE ATLANTA GEORGIA, UNITED STATES

Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0 | $354,957.00September 4, 2025

National Institutes of Health, a sub agency of Department of Health and Human Services, issued a payment of $354,957.00 to METACLIPSE THERAPEUTICS CORP. The payment included a Subsidy Cost of $0.00.